These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12354358)

  • 1. New markers for cancer detection.
    Wong IH; Lo YM
    Curr Oncol Rep; 2002 Nov; 4(6):471-7. PubMed ID: 12354358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation profiling of human cancers in blood: molecular monitoring and prognostication (review).
    Wong IH
    Int J Oncol; 2001 Dec; 19(6):1319-24. PubMed ID: 11713606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma nucleic acids in the diagnosis and management of malignant disease.
    Johnson PJ; Lo YM
    Clin Chem; 2002 Aug; 48(8):1186-93. PubMed ID: 12142371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating nucleic acids (CNAs) and cancer--a survey.
    Fleischhacker M; Schmidt B
    Biochim Biophys Acta; 2007 Jan; 1775(1):181-232. PubMed ID: 17137717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma.
    Tian F; Yip SP; Kwong DL; Lin Z; Yang Z; Wu VW
    Cancer Epidemiol; 2013 Oct; 37(5):708-13. PubMed ID: 23790641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring.
    Wong IH; Lo YM; Johnson PJ
    Ann N Y Acad Sci; 2001 Sep; 945():36-50. PubMed ID: 11708493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the knowledge of circulating nucleic acids: plasma RNA is particle-associated. Can it become a general detection marker for a cancer blood test?
    Anker P; Stroun M
    Clin Chem; 2002 Aug; 48(8):1210-1. PubMed ID: 12142375
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.
    Xi L; Nicastri DG; El-Hefnawy T; Hughes SJ; Luketich JD; Godfrey TE
    Clin Chem; 2007 Jul; 53(7):1206-15. PubMed ID: 17525108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating nucleic acids as a tumor marker.
    Chan KC; Lo YM
    Histol Histopathol; 2002; 17(3):937-43. PubMed ID: 12168805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Cancer Therapy: Liquid Biopsy.
    Marmé D
    Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating Biomarkers for Prediction of Treatment Response.
    Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
    Wu CH; Lin SR; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Huang SY; Wang JY
    Dis Markers; 2006; 22(3):103-9. PubMed ID: 16788243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?
    Anker P; Mulcahy H; Stroun M
    Int J Cancer; 2003 Jan; 103(2):149-52. PubMed ID: 12455027
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
    Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
    Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
    Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
    Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
    J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
    Burchill SA; Bradbury MF; Pittman K; Southgate J; Smith B; Selby P
    Br J Cancer; 1995 Feb; 71(2):278-81. PubMed ID: 7530983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling of circulating tumor cells: quantification and cancer progression (Review).
    Wong IH
    Oncol Rep; 2003; 10(1):229-35. PubMed ID: 12469174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.